ITherapeutics ERUM Non-Confidential Information Presentation November 2022 Oral and IV treatment for serious bacterial infections ERUM 1 ITherapeutics Forward-looking Statements & Disclaimer This Confidential Overview (this "Overview") contains forward-looking statements. These forward-looking statements include, without limitation, statements regarding the development, therapeutic and market potential of sulopenem, the granting or issuing of patents, the timing, progress and results of clinical trials, the ...